ANGIOCLAST

angioclast-logo

angioClast is a Cambridge biotech startup comitted to transform cancer research. Through the application of de novo markers of cancer blood vessels, angioClast strives to develop and revolutionize the treatment and diagnosis of various cancer types.

#SimilarOrganizations #People #Financial #Event #Website #More

ANGIOCLAST

Social Links:

Industry:
Biotechnology Health Care Medical Oncology

Founded:
2015-01-01

Address:
Cambridge, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.angioclast.co.uk

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Georgian Server Location


Similar Organizations

ankrin-therapeutics-logo

Ankrin Therapeutics

Ankrin Therapeutics is a biotechnology startup that develops drugs for cancer treatment.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

biden-cancer-initiative-logo

Biden Cancer Initiative

The Biden Cancer Initiative is determined to bring urgency to the fight against cancer and to transform cancer research.

iov-logo

IOV

IOV is a healthcare firm that offers cancer treatment, cancer diagnostics, oncological surgery, and cancer research services.

nbe-therapeutics-logo

NBE-Therapeutics

NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.

oncompass-logo

ONCOMPASS

ONCOMPASS is a molecular diagnostics based therapeutic information service for precision oncology.

oncotherm-logo

Oncotherm

OncoTherm is a medical device company that develops, manufactures and markets cancer treatment devices.

radium-hospital-research-foundation-logo

Radium Hospital Research Foundation

Radium Hospital Research Foundation is a commercial enterprise geared towards cancer research.

wales-cancer-biobank-logo

Wales Cancer Biobank

Wales Cancer Biobank offers a wide range of services to support involvement, participation, and engagement in cancer research.

Current Employees Featured

minaam-abbas_image

Minaam Abbas
Minaam Abbas Chief Operating Officer @ angioClast
Chief Operating Officer
2016-12-01

juba-tsuladze_image

Juba Tsuladze
Juba Tsuladze CEO & Co-founder @ angioClast
CEO & Co-founder

Founder


juba-tsuladze_image

Juba Tsuladze

minaam-abbas_image

Minaam Abbas

Investors List

pitchpalace_image

Pitch@Palace

Pitch@Palace investment in Non Equity Assistance - angioClast

Newest Events participated

pitchpalace-50_event_image Participated in Pitch@Palace 5.0 on 2016-03-07 as exhibitor

Official Site Inspections

http://www.angioclast.co.uk

  • Host name: a67c48129651a0940.awsglobalaccelerator.com
  • IP address: 76.223.67.189
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "angioClast"

angioClast Company Profile | Management and Employees List

AngioClast Profile and History. angioClast is a biotech startup founded in 2015 by a group of University of Cambridge affiliates in Cambridge, UK. Our Mission Statement: We focus on โ€ฆSee details»

AngioClast Company Profile 2024: Valuation, Funding โ€ฆ

AngioClast General Information Description. Developer of an anti-angiogenic treatment designed to transform cancer therapy. The company's treatment โ€ฆSee details»

angioClast - Cambridge Judge Business School

AngioClastโ€™s business model is to license out a patent from the National Institute of Health through the NIH start-up exclusive licensing agreement, and harness the value of newly identified โ€ฆSee details»

angioClast Overview | SignalHire Company Profile

AngioClast is a biotech startup founded in 2015 by a group of University of Cambridge affiliates in Cambridge, UK. Our Mission Statement: We focus on utilizing molecular techniques to dev...See details»

angioClast - VentureRadar

Through the application of de novo markers of cancer blood vessels, angioClast strives to develop and revolutionize the treatment and diagnosis of various cancer types. VentureRadar โ€ฆSee details»

AngioClast Company Profile - Office Locations, Competitors ... - Craft

See insights on AngioClast including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

angioClast - Overview, News & Similar companies | ZoomInfo.com

Who is angioClast. angioClast is a biotech startup founded in 2015 by a group of University of Cambridge affiliates in Cambridge, UK.Our Mission Statement: We focus on utilizing molecular โ€ฆSee details»

Angioclast - Products, Competitors, Financials, Employees, โ€ฆ

Angioclast is a biotech startup with a focus on developing treatments for brain cancer. Use the CB Insights Platform to explore Angioclast's full profile. Angioclast - Products, Competitors, โ€ฆSee details»

angioClast - Funding, Financials, Valuation & Investors - Crunchbase

Mar 7, 2016 angioClast is a Cambridge biotech startup comitted to transform cancer research. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. โ€ฆSee details»

angioClast - Tech Stack, Apps, Patents & Trademarks - Crunchbase

AngioClast is a Cambridge biotech startup comitted to transform cancer research.See details»

angioClast - Crunchbase

AngioClast is a Cambridge biotech startup comitted to transform cancer research.See details»

angioClast Ltd.: Drug pipelines, Patents, Clinical trials - Synapse

Jun 28, 2023 Explore angioClast Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Angioclast - Company Profile - Tracxn

Angioclast - UK-based, early-stage drug discovery & development company that is developing therapeutics for brain cancer. from 5 investors. Founded by Krish Vallurupalli, Juba Tsuladze โ€ฆSee details»

From the lab bench to the patient's bedside | Cambridge Network

Minaam [2017], who will begin his PhD this autumn as a Gates Cambridge Scholar, is chief operating officer of angioClast, a company which aims to develop drugs that can target blood โ€ฆSee details»

From the lab bench to the patientโ€™s bedside - Gates Cambridge

Apr 12, 2017 Minaam [2017], who will begin his PhD this autumn as a Gates Cambridge Scholar, is chief operating officer of angioClast, a company which aims to develop drugs that โ€ฆSee details»

angioClast - YouTube

AngioClast is a cambridge based drug delivery company transforming the cancer therapySee details»

angioClast - Contacts, Employees, Board Members, Advisors

AngioClast is a Cambridge biotech startup comitted to transform cancer research.See details»

Top AngioClast Competitors and Alternatives | Craft.co

AngioClast's main competitors include Acorda Therapeutics, Codiak Biosciences, Kartos Therapeutics and Polyplus-transfection. Compare AngioClast to its competitors by revenue, โ€ฆSee details»

Minaam Abbas - Chief Operating Officer @ angioClast - Crunchbase

Primary Organization . angioClast . Location Cambridge, Cambridgeshire, United Kingdom; Regions Europe, Middle East, and Africa (EMEA ... Minaam Abbas is the Chief Operating โ€ฆSee details»

linkstock.net © 2022. All rights reserved